Antimicrobial resistance (AMR)

The MICROBE (Measuring Infectious Causes and Resistance Outcomes for Burden Estimation) tool visualizes the fatal and nonfatal health outcomes of infections, pathogens, and antimicrobial resistance across different countries and regions.

By 2050, deaths from antibiotic-resistant infections could rise by roughly two-thirds unless the world intervenes.

As per the latest estimates of antimicrobial resistance (AMR) on a global level, at least 1.27 million deaths per year are directly attributable to AMR.

To estimate the global burden of AMR we are seeking anonymised, non-identifiable data from 1990 onward, including patient-level microbiology data, clinical records, and patient outcomes.

To address the growing threat of antimicrobial resistance (AMR), leaders in global health research came together to create the Global Research on Antimicrobial Resistance (GRAM) Project, a partnership between IHME and the University of Oxford.

Our research suggests that deaths from antibiotic resistance will accelerate over the next 30 years, and combatting this threat will require a One Health approach.

Antimicrobial resistance (AMR) is a global health threat and growing problem.

We present the findings of a research paper on anti-microbial resistance, published in The Lancet.